Real-time enrollment status for this rare histiocytic disorders (rhds) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:39 AM UTC
| NCT Number | NCT02285582 |
| Recruiting Status | Recruiting |
| Condition | Rare Histiocytic Disorders (RHDs) |
| Phase | Clinical Trial |
| Target Enrollment | 400 participants |
| Active Locations | 6 sites in the US |
| Sponsor | The Hospital for Sick Children |
| Last Updated on CT.gov | June 24, 2025 (Jun 24, 2025) |
As of July 13, 2026: Clinical trial NCT02285582 is currently recruiting participants. This clinical trial study for rare histiocytic disorders (rhds) is actively seeking new participants at 6 locations across the United States. The study is sponsored by The Hospital for Sick Children. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02285582 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02285582 was last updated Jun 24, 2025 (June 24, 2025). HelloStudys verifies this status automatically.